Hypoxia-independent drivers of melanoma angiogenesis

Frontiers in Oncology

Volumn 5, Issue MAY, 2015, Pages

  Meierjohann, Svenja ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Angiogenesis; Hypoxia independent; Melanoma; NF B; Reactive oxygen species

Indexed keywords

ANGIOGENIN; ANGIOPOIETIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MATRIX METALLOPROTEINASE 14; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; UROKINASE; VASCULOTROPIN;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HYPOXIA; MELANOCYTE; MELANOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SHORT SURVEY; TUMOR GROWTH; TUMOR VASCULARIZATION; UNFOLDED PROTEIN RESPONSE; XENOGRAFT;

EID: 84934268385     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00102     Document Type: Short Survey

References (89)

1. Zaidi MR, Day CP, Merlino G. From UVs to metastases: modeling melanoma initiation and progression in the mouse. J Invest Dermatol (2008) 128:2381-91. doi: 10.1038/jid.2008.177
2. Ria R, Reale A, Castrovilli A, Mangialardi G, Dammacco F, Ribatti D, et al. Angiogenesis and progression in human melanoma. Dermatol Res Pract (2010) 2010:185687. doi:10.1155/2010/185687
3. Goldstein LJ, Chen H, Bauer RJ, Bauer SM, Velazquez OC. Normal human fibroblasts enable melanoma cells to induce angiogenesis in type I collagen. Surgery (2005) 138:439-49. doi:10.1016/j.surg.2005.06.031
4. Schumacker PT, Samsel RW. Analysis of oxygen delivery and uptake relationships in the Krogh tissue model. J Appl Physiol (1985) (1989) 67:1234-44.
5. Gasparini G. The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs (1999) 58:17-38. doi:10.2165/00003495-199958010-00003
6. Zhao C, Yang H, Shi H, Wang X, Chen X, Yuan Y, et al. Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases. Carcinogenesis (2011) 32:1143-50. doi:10.1093/carcin/bgr076
7. Laisney JA, Braasch I, Walter RB, Meierjohann S, Schartl M. Lineage-specific co-evolution of the Egf receptor/ligand signaling system. BMC Evol Biol (2010) 10:27. doi:10.1186/1471-2148-10-27
8. Laisney JA, Mueller TD, Schartl M, Meierjohann S. Hyperactivation of constitutively dimerized oncogenic EGF receptors by autocrine loops. Oncogene (2013) 32:2403-11. doi:10.1038/onc.2012.267
9. Schartl M, Wilde B, Laisney JA, Taniguchi Y, Takeda S, Meierjohann S. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies. J Invest Dermatol (2010) 130:249-58. doi:10.1038/jid.2009.213
10. Schartl M, Kneitz S, Wilde B, Wagner T, Henkel CV, Spaink HP, et al. Conserved expression signatures between medaka and human pigment cell tumors. PLoS One (2012) 7:e37880. doi:10.1371/journal.pone.0037880
11. Wittbrodt J, Adam D, Malitschek B, Maueler W, Raulf F, Telling A, et al. Novel putative receptor tyrosine kinase encoded by the melanoma-inducing Tu locus in Xiphophorus. Nature (1989) 341:415-21. doi:10.1038/341415a0
12. Anders F. Contributions of the Gordon-Kosswig melanoma system to the present concept of neoplasia. Pigment Cell Res (1991) 4:7-29. doi:10.1111/j.1600-0749.1991.tb00309.x
13. Schaafhausen MK, Yang WJ, Centanin L, Wittbrodt J, Bosserhoff A, Fischer A, et al. Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-kappaB. J Cell Sci (2013) 126:3862-72. doi:10.1242/jcs.125021
14. Cao Y, Li CY, Moeller BJ, Yu D, Zhao Y, Dreher MR, et al. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res (2005) 65:5498-505. doi:10.1158/0008-5472.CAN-04-4553
15. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (< or =1.0 mm) are associated with angiogenesis. Am J Pathol (1993) 143:99-104.
16. Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest (2013) 123:3664-71. doi:10.1172/JCI67230
17. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol (2004) 5:343-54. doi:10.1038/nrm1366
18. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol (2006) 59:15-26. doi:10.1016/j.critrevonc.2005.12.003
19. Simon MP, Tournaire R, Pouyssegur J. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol (2008) 217:809-18. doi:10.1002/jcp.21558
20. Sebastia J, Kieran D, Breen B, King MA, Netteland DF, Joyce D, et al. Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ (2009) 16:1238-47. doi:10.1038/cdd.2009.52
21. Nys K, Maes H, Dudek AM, Agostinis P. Uncovering the role of hypoxia inducible factor-1alpha in skin carcinogenesis. Biochim Biophys Acta (2011) 1816:1-12. doi:10.1016/j.bbcan.2011.02.001
22. Zbytek B, Peacock DL, Seagroves TN, Slominski A. Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol (2013) 5:239-51. doi:10.4161/derm.22678
23. Bedogni B, Welford SM, Cassarino DS, Nickoloff BJ, Giaccia AJ, Powell MB. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell (2005) 8:443-54. doi:10.1016/j.ccr.2005.11.005
24. Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res (2003) 13:493-501. doi:10.1097/00008390-200310000-00008
25. Bosserhoff AK, Ellmann L, Kuphal S. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma. Exp Dermatol (2011) 20:435-40. doi:10.1111/j.1600-0625.2011.01271.x
26. Hanna SC, Krishnan B, Bailey ST, Moschos SJ, Kuan PF, Shimamura T, et al. HIF1alpha and HIF2alpha independently activate SRC to promote melanoma metastases. J Clin Invest (2013) 123:2078-93. doi:10.1172/JCI66715
27. Mills CN, Joshi SS, Niles RM. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions. Mol Cancer (2009) 8:104. doi:10.1186/1476-4598-8-104
28. Kumar SM, Yu H, Edwards R, Chen L, Kazianis S, Brafford P, et al. Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res (2007) 67:3177-84. doi:10.1158/0008-5472.CAN-06-3312
29. Li YM, Zhou BP, Deng J, Pan Y, Hay N, Hung MC. A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells. Cancer Res (2005) 65:3257-63. doi:10.1158/0008-5472.CAN-04-1284
30. Fang J, Ding M, Yang L, Liu LZ, Jiang BH. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal (2007) 19:2487-97. doi:10.1016/j.cellsig.2007.07.025
31. Bian CX, Shi Z, Meng Q, Jiang Y, Liu LZ, Jiang BH. P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression. Biochem Biophys Res Commun (2010) 398:395-9. doi:10.1016/j.bbrc.2010.06.080
32. Spinella F, Rosano L, Del Duca M, Di Castro V, Nicotra MR, Natali PG, et al. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells. PLoS One (2010) 5:e11241. doi:10.1371/journal.pone.0011241
33. van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J (2008) 412:477-84. doi:10.1042/BJ20080476
34. Kuphal S, Winklmeier A, Warnecke C, Bosserhoff AK. Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer (2010) 46:1159-69. doi:10.1016/j.ejca.2010.01.031
35. Madonna G, Ullman CD, Gentilcore G, Palmieri G, Ascierto PA. NF-kappaB as potential target in the treatment of melanoma. J Transl Med (2012) 10:53. doi:10.1186/1479-5876-10-53
36. Meierjohann S. Oxidative stress in melanocyte senescence and melanoma transformation. Eur J Cell Biol (2014) 93:36-41. doi:10.1016/j.ejcb.2013.11.005
37. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell (1993) 74:395-404. doi:10.1016/0092-8674(93)90429-T
38. Opdecamp K, Nakayama A, Nguyen MT, Hodgkinson CA, Pavan WJ, Arnheiter H. Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development (1997) 124:2377-86.
39. Hartman ML, Czyz M. Pro-survival role of MITF in melanoma. J Invest Dermatol (2015) 135:352-8. doi:10.1038/jid.2014.319
40. Busca R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, et al. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J Cell Biol (2005) 170:49-59. doi:10.1083/jcb.200501067
41. Cheli Y, Ohanna M, Ballotti R, Bertolotto C. Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res (2010) 23:27-40. doi:10.1111/j.1755-148X.2009.00653.x
42. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS, et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev (2006) 20:3426-39. doi:10.1101/gad.406406
43. Giuliano S, Cheli Y, Ohanna M, Bonet C, Beuret L, Bille K, et al. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res (2010) 70:3813-22. doi:10.1158/0008-5472.CAN-09-2913
44. Loercher AE, Tank EM, Delston RB, Harbour JW. MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol (2005) 168:35-40. doi:10.1083/jcb.200410115
45. Wellbrock C, Marais R. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol (2005) 170:703-8. doi:10.1083/jcb.200505059
46. Bertolotto C, Lesueur F, Giuliano S, Strub T, De Lichy M, Bille K, et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature (2011) 480:94-8. doi:10.1038/nature10539
47. Ryan HE, Poloni M, Mcnulty W, Elson D, Gassmann M, Arbeit JM, et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res (2000) 60:4010-5.
48. Yang Y, Wu J, Demir A, Castillo-Martin M, Melamed RD, Zhang G, et al. GAB2 induces tumor angiogenesis in NRAS-driven melanoma. Oncogene (2013) 32:3627-37. doi:10.1038/onc.2012.367
49. Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, et al. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene (1999) 18:4718-25. doi:10.1038/sj.onc.1202850
50. Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, et al. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ Res (2009) 104:1169-77. doi:10.1161/CIRCRESAHA.109.196592
51. Craige SM, Chen K, Pei Y, Li C, Huang X, Chen C, et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation (2011) 124:731-40. doi:10.1161/CIRCULATIONAHA.111.030775
52. Chen JX, Zeng H, Lawrence ML, Blackwell TS, Meyrick B. Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase. Am J Physiol Heart Circ Physiol (2006) 291:H1563-72. doi:10.1152/ajpheart.01081.2005
53. Abid MR, Spokes KC, Shih SC, Aird WC. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J Biol Chem (2007) 282:35373-85. doi:10.1074/jbc.M702175200
54. Wang H, Yang Z, Jiang Y, Hartnett ME. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity. Mol Vis (2014) 20:231-41.
55. Leikam C, Hufnagel A, Schartl M, Meierjohann S. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene (2008) 27:7070-82. doi:10.1038/onc.2008.323
56. Leikam C, Hufnagel A, Walz S, Kneitz S, Fekete A, Muller MJ, et al. Cystathionase mediates senescence evasion in melanocytes and melanoma cells. Oncogene (2014) 33:771-82. doi:10.1038/onc.2012.641
57. Lokaj K, Meierjohann S, Schutz C, Teutschbein J, Schartl M, Sickmann A. Quantitative differential proteome analysis in an animal model for human melanoma. J Proteome Res (2009) 8:1818-27. doi:10.1021/pr800578a
58. Huang S, Deguzman A, Bucana CD, Fidler IJ. Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res (2000) 6:2573-81.
59. Gao K, Dai DL, Martinka M, Li G. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration. Cancer Res (2006) 66:8382-8. doi:10.1158/0008-5472.CAN-05-4402
60. Karst AM, Gao K, Nelson CC, Li G. Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. Int J Cancer (2009) 124:494-501. doi:10.1002/ijc.23973
61. Wani AA, Jafarnejad SM, Zhou J, Li G. Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappaB/interleukin-6 signaling pathway. Oncogene (2011) 30:2778-88. doi:10.1038/onc.2010.644
62. Li J, Cheng Y, Tai D, Martinka M, Welch DR, Li G. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene (2011) 30:896-906. doi:10.1038/onc.2010.470
63. Okuno Y, Nakamura-Ishizu A, Otsu K, Suda T, Kubota Y. Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat Med (2012) 18:1208-16. doi:10.1038/nm.2846
64. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol (2013) 53:401-26. doi:10.1146/annurev-pharmtox-011112-140320
65. Afonyushkin T, Oskolkova OV, Philippova M, Resink TJ, Erne P, Binder BR, et al. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways. Arterioscler Thromb Vasc Biol (2010) 30:1007-13. doi:10.1161/ATVBAHA.110.204354
66. Afonyushkin T, Oskolkova OV, Binder BR, Bochkov VN. Involvement of CK2 in activation of electrophilic genes in endothelial cells by oxidized phospholipids. J Lipid Res (2011) 52:98-103. doi:10.1194/jlr.M009480
67. Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM, et al. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res (2011) 71:2260-75. doi:10.1158/0008-5472.CAN-10-3007
68. Zhang Z, Wang Q, Ma J, Yi X, Zhu Y, Xi X, et al. Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1alpha signaling in human epithelial ovarian cancer. Oncol Rep (2013) 29:1429-34. doi:10.3892/or.2013.2278
69. Ji X, Wang H, Zhu J, Zhu L, Pan H, Li W, et al. Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Int J Cancer (2014) 135:574-84. doi:10.1002/ijc.28699
70. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol (2006) 91:807-19. doi:10.1113/expphysiol.2006.033506
71. Calvani M, Comito G, Giannoni E, Chiarugi P. Time-dependent stabilization of hypoxia inducible factor-1alpha by different intracellular sources of reactive oxygen species. PLoS One (2012) 7:e38388. doi:10.1371/journal.pone.0038388
72. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 155:739-52. doi:10.1016/S0002-9440(10)65173-5
73. Thies A, Mangold U, Moll I, Schumacher U. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol (2001) 195:537-42. doi:10.1002/path.988
74. Vartanian AA, Burova OS, Stepanova EV, Baryshnikov AY, Lichinitser MR. Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level. Melanoma Res (2007) 17:370-9. doi:10.1097/CMR.0b013e3282f1d2ec
75. Biswas SK, Lewis CE. NF-kappaB as a central regulator of macrophage function in tumors. J Leukoc Biol (2010) 88:877-84. doi:10.1189/jlb.0310153
76. Yan L, Yee JA, Mcguire MH, Graef GL. Effect of dietary supplementation of selenite on pulmonary metastasis of melanoma cells in mice. Nutr Cancer (1997) 28:165-9. doi:10.1080/01635589709514570
77. Yan L, Yee JA, Li D, Mcguire MH, Graef GL. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Res (1999) 19:1337-42.
78. Tosetti F, Ferrari N, De Flora S, Albini A. Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J (2002) 16:2-14. doi:10.1096/fj.01-0300rev
79. Wang M, Kaufman RJ. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer (2014) 14:581-97. doi:10.1038/nrc3800
80. Yadav RK, Chae SW, Kim HR, Chae HJ. Endoplasmic reticulum stress and cancer. J Cancer Prev (2014) 19:75-88. doi:10.15430/JCP.2014.19.2.75
81. Wang Y, Alam GN, Ning Y, Visioli F, Dong Z, Nor JE, et al. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway. Cancer Res (2012) 72:5396-406. doi:10.1158/0008-5472.CAN-12-0474
82. Pereira ER, Liao N, Neale GA, Hendershot LM. Transcriptional and post-transcriptional regulation of proangiogenic factors by the unfolded protein response. PLoS One (2010) 5:e12521. doi:10.1371/journal.pone.0012521
83. Zhuang L, Scolyer RA, Lee CS, Mccarthy SW, Cooper WA, Zhang XD, et al. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology (2009) 54:462-70. doi:10.1111/j.1365-2559.2009.03242.x
84. Xue Y, Petrovic N, Cao R, Larsson O, Lim S, Chen S, et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab (2009) 9:99-109. doi:10.1016/j.cmet.2008.11.009
85. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature (2008) 451:1008-12. doi:10.1038/nature06613
86. Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, et al. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell (2013) 23:287-301. doi:10.1016/j.ccr.2012.11.020
87. Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, et al. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell (2013) 23:302-15. doi:10.1016/j.ccr.2013.02.003
88. Damsky WE, Theodosakis N, Bosenberg M. Melanoma metastasis: new concepts and evolving paradigms. Oncogene (2014) 33:2413-22. doi:10.1038/onc.2013.194
89. Ulmer A, Dietz K, Hodak I, Polzer B, Scheitler S, Yildiz M, et al. Quantitative measurement of melanoma spread in sentinel lymph nodes and survival. PLoS Med (2014) 11:e1001604. doi:10.1371/journal.pmed.1001604